207 related articles for article (PubMed ID: 29849523)
21. Enzymatic Versus Traditional Surgical Debridement of Severely Burned Hands: A Comparison of Selectivity, Efficacy, Healing Time, and Three-Month Scar Quality.
Schulz A; Shoham Y; Rosenberg L; Rothermund I; Perbix W; Christian Fuchs P; Lipensky A; Schiefer JL
J Burn Care Res; 2017; 38(4):e745-e755. PubMed ID: 28644207
[TBL] [Abstract][Full Text] [Related]
22. Limitations to the use of bromelain-based enzymatic debridement (NexoBrid
Berner JE; Keckes D; Pywell M; Dheansa B
Scars Burn Heal; 2018; 4():2059513118816534. PubMed ID: 30574406
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic debridement in critically injured burn patients - Our experience in the intensive care setting and during burn resuscitation.
Bowers C; Randawa A; Sloan B; Anwar U; Phipps A; Muthayya P
Burns; 2022 Jun; 48(4):846-859. PubMed ID: 34493422
[TBL] [Abstract][Full Text] [Related]
24. An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence.
Loo YL; Goh BKL; Jeffery S
J Burn Care Res; 2018 Oct; 39(6):932-938. PubMed ID: 29579268
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic debridement of hands with deep burns: a single center experience in the treatment of 52 hands.
Dadras M; Wagner JM; Wallner C; Sogorski A; Sacher M; Harati K; Lehnhardt M; Behr B
J Plast Surg Hand Surg; 2020 Aug; 54(4):220-224. PubMed ID: 32315252
[No Abstract] [Full Text] [Related]
26. Historical Perspectives on the Development of Current Standards of Care for Enzymatic Debridement.
Heitzmann W; Fuchs PC; Schiefer JL
Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33348927
[No Abstract] [Full Text] [Related]
27. Escharotomy using an enzymatic debridement agent for treating experimental burn-induced compartment syndrome in an animal model.
Krieger Y; Rosenberg L; Lapid O; Glesinger R; Bogdanov-Berezovsky A; Silberstein E; Sagi A; Judkins K
J Trauma; 2005 Jun; 58(6):1259-64. PubMed ID: 15995479
[TBL] [Abstract][Full Text] [Related]
28. Selectivity of a bromelain based enzymatic debridement agent: a porcine study.
Rosenberg L; Krieger Y; Silberstein E; Arnon O; Sinelnikov IA; Bogdanov-Berezovsky A; Singer AJ
Burns; 2012 Nov; 38(7):1035-40. PubMed ID: 22385643
[TBL] [Abstract][Full Text] [Related]
29. A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.
Korzeniowski T; Strużyna J; Chrapusta AM; Krajewski A; Kucharzewski M; Piorun K; Nowakowski J; Surowiecka A; Kozicka M; Torres K
Med Sci Monit; 2022 Jan; 28():e935632. PubMed ID: 35064095
[TBL] [Abstract][Full Text] [Related]
30. Does Enzymatic Debridement Allow Us To Perform Conservative Treatment On Clinically Deep Hand Burns? A Retrospective Review.
Rivas-Nicolls D; Aguilera-Sáez J; Gallardo-Calero I; Serracanta J; Gomez P; Palao R; Barret JP
Ann Burns Fire Disasters; 2020 Sep; 33(3):239-244. PubMed ID: 33304215
[TBL] [Abstract][Full Text] [Related]
31. To bleed or not to bleed? Case series and discussion of haemorrhage risk with enzymatic debridement in burn injuries.
Hasham S; Riyat H; Fletcher A; O'Boyle CP; Alexander S
Scars Burn Heal; 2023; 9():20595131231168333. PubMed ID: 37124159
[TBL] [Abstract][Full Text] [Related]
32. Helpful hints in deciding what and when to operate after enzymatic debridement.
Claes KEY; De Decker I; Monstrey S; Shoham Y; Vyncke T; Depypere B; De Wolf E; Decuypere F; Lannau B; Hoeksema H
Burns; 2023 Feb; 49(1):80-90. PubMed ID: 35177282
[TBL] [Abstract][Full Text] [Related]
33. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
Schulz A; Fuchs PC; Rothermundt I; Hoffmann A; Rosenberg L; Shoham Y; Oberländer H; Schiefer J
Burns; 2017 Sep; 43(6):1233-1243. PubMed ID: 28363663
[TBL] [Abstract][Full Text] [Related]
34. Implementing Nexobrid for Burn Debridement in a Major Italian Burn Center: A Retrospective Review of Patient Outcomes.
Lombardo GAG; Ciancio F; Violini H; Sapuppo C; Zagami S; Vena A; Giardina M; Donia C; Ranno R
J Burn Care Res; 2024 Mar; 45(2):432-437. PubMed ID: 37897805
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic debridement for the treatment of severely burned upper extremities - early single center experiences.
Cordts T; Horter J; Vogelpohl J; Kremer T; Kneser U; Hernekamp JF
BMC Dermatol; 2016 Jun; 16(1):8. PubMed ID: 27342276
[TBL] [Abstract][Full Text] [Related]
36. Human cadaver model as a training tool for enzymatic burn debridement (Nexobrid®): A feasibility study.
Wen J; Johnson K; O'Boyle CP
Burns; 2022 Nov; 48(7):1706-1709. PubMed ID: 35210140
[TBL] [Abstract][Full Text] [Related]
37. The use of NexoBrid™ enzymatic debridement and coagulation abnormalities.
Capitelli-McMahon H; McCrossan S; Kershaw J; Muthayya P; Anwar MU; Carter A; Sloan B
Burns; 2024 Feb; 50(1):123-131. PubMed ID: 37827936
[TBL] [Abstract][Full Text] [Related]
38. The effects of rapid enzymatic debridement of deep partial-thickness burns with Debrase on wound reepithelialization in swine.
Singer AJ; Taira BR; Anderson R; McClain SA; Rosenberg L
J Burn Care Res; 2010; 31(5):795-802. PubMed ID: 20661148
[TBL] [Abstract][Full Text] [Related]
39. Clinical Value of Debriding Enzymes as an Adjunct to Standard Early Surgical Excision in Human Burns: A Systematic Review.
Salehi SH; Momeni M; Vahdani M; Moradi M
J Burn Care Res; 2020 Nov; 41(6):1224-1230. PubMed ID: 32424404
[TBL] [Abstract][Full Text] [Related]
40. Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience.
Ho W; Jones CD; Widdowson D; Bahia H
J Wound Care; 2019 Nov; 28(11):758-761. PubMed ID: 31721672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
